The Prevalence of Fibrocystic Changes of Breast Tissue of Patients who Underwent Reduction Mammoplasty in Rasool-Akram, Firuzgar and Sadr Hospitals during 2007-2012
Advances in Surgical Sciences
Volume 2, Issue 1, February 2014, Pages: 5-8
Received: Jan. 18, 2014; Published: Mar. 20, 2014
Views 2948      Downloads 146
Authors
Mostafa Hosseini, Surgical department of Iran University of medical science, Tehran, Iran
Adnan Tizmaghz, Surgical department of Iran University of medical science, Tehran, Iran
Hamidreza Alizadeh Otaghvar, Surgical department of Iran University of medical science, Tehran, Iran
Marjan Shams, Surgical department of Iran University of medical science, Tehran, Iran
Article Tools
PDF
Follow on us
Abstract
Introduction: Fibrocystic changes are considered as common and benign changes in the breast tissue. This study aimed to determine the prevalence of pathologic changes Including fibrocystic changes, hyperplasia, and carcinoma in breast tissue specimens of patients underwent reduction Mammoplasty.Methods: 128 consecutive patients over a period of 5 years from 2007 to 2012, who were admitted at the Rasool-Akram, Firoozgar, and Sadr Hospitals for reduction mammoplasty, were investigated in this study. In all patients an average of 500 grams of breast tissue from each side during mammoplasty was sent for pathologic evaluation. The variables measured in the study included age, fibrocystic changes, and hyperplastic changes in the pathology specimens of these patients. Data analysis was performed using SPSS 18 software. Results: 71 patients (55.5%) had fibrocystic changes. 6 patients (4.7%) were reported to have hyperplasia. Carcinoma was not observed in any of the samples. The prevalence of fibrocystic changes increased with age. Hyperplastic changes were not associated with age and with fibrocystic changes. But it was the most common in the ages between 31 and 40 years. Conclusion: Fibrocystic breast changes are common, and their prevalence increases with age. However, they are not associated with hyperplasia and cancer risk.
Keywords
Breast Fibrocystic Changes, Pathology, Mammoplasty
To cite this article
Mostafa Hosseini, Adnan Tizmaghz, Hamidreza Alizadeh Otaghvar, Marjan Shams, The Prevalence of Fibrocystic Changes of Breast Tissue of Patients who Underwent Reduction Mammoplasty in Rasool-Akram, Firuzgar and Sadr Hospitals during 2007-2012, Advances in Surgical Sciences. Vol. 2, No. 1, 2014, pp. 5-8. doi: 10.11648/j.ass.20140201.12
References
[1]
Wu C, Ray RM, Lin MG, et al. A case-control study of risk factors forfibrocystic Breast conditions. Am J Epidemiol 2004; 160:945-960.
[2]
Kabat GC, Jones JG, Olson N. A multi-center prospective cohort study ofbenign breast disease and risk of subsequent breast cancer. Cancer Causes Control2010; 21:821-828.
[3]
Boschert MT, Barone CM, Puckett CL. Outcome analysis of reductionmammaplasty. PlastReconstr Surg. 1996;98:451-4.
[4]
London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospectivestudy of benignbreast disease and the risk of breast cancer.JAMA 1992; 267:941-944.
[5]
Cotran., Kumar., Collins Robbins Pathologic basis of disease, 6 thed b Philadelphia, Saunders company, 1999, PP: 1098-1100.
[6]
Dotto J, Kluk M, Geramizadeh B, Tavassoli FA. Frequency of clinically occultintraepithelial and invasive neoplasia in reduction mammoplasty specimens: astudy of 516 cases. Int J SurgPathol. 2008 Jan;16(1):25-30.
[7]
Samdanci ET, Firat C, Cakir E, Ak M, Sayin S, Nurkabul Z. The incidence ofnon-proliferative and precancerous lesions of reduction mammoplasty: evaluationof 273 cases. Eur Rev Med PharmacolSci 2011;15(10):1207-11.
[8]
Ambaye AB, MacLennan SE, Goodwin AJ, Suppan T, Naud S, Weaver DL.Carcinoma and atypical hyperplasia in reduction mammaplasty: increasedsampling leads to increased detection. A prospective study.PlastReconstrSurg2009 Nov;124(5):1386-92.
[9]
Clark CJ, Whang S, Paige KT. Incidence of precancerous lesions in breastreduction tissue: a pathologic review of 562 consecutive patients. PlastReconstrSurg 2009;124(4):1033-9.
[10]
Ayhan S, Başterzi Y, Yavuzer R, Latifoğlu O, Cenetoğlu S, Atabay K, et al.Histologic profiles of breast reduction specimens. Aesthetic PlastSurg 2002;26(3):203-5.
[11]
Kyriopoulos E, Kakagia D, Zapandioti P, Papaliodi E, Tsoutsos D. Pathologicfindings in breast reduction specimens: detection of occult premalignant andcancerous lesions. Onkologie. 2012;35(10):583-6.
[12]
Pitanguy I, Torres E, Salgado F, PiresViana GA. Breast pathology and reduction mammaplasty. PlastReconstr Surg. 2005 Mar;115(3):729-34; discussion735.
[13]
Blansfield JA, Kukora JS, Goldhahn RT Jr, Buinewicz BR. Suspicious findingsin reduction mammaplasty specimens: review of 182 consecutive patients. AnnPlast Surg. 2004 Feb;52(2):126-30.
[14]
Viana GA, Pitanguy I, Torres E. Histopathological findings in surgicalspecimens obtained from reduction mammaplasties. Breast. 2005 Jun;14(3):242-8
[15]
http://www.mckinley.illinois.edu/handouts/breast_health/breast_health.html
[16]
Berek and Novaks, Gynecology, 14th edition, 2007, pages 637-659.
[17]
Up To Date, 2012
[18]
Stenchever, Morton A., Droegemuller, William, Herbst, Arthur, Mishell, Daniel R., Comprehensive Gynecology, 54th Edition; Mosby 2007, pages 327-357.
[19]
Benign Breast Disease and Breast Cancer Tutorial; Dr. William H. Goldberg, University of Wisconsin
[20]
National Institute of Health. "Breast Diseases" MEDLINEplus Medical Encyclopedia, a service of the U.S. National Library and the National Institute of Health web site: http://www.nlm.nih.gov/medlineplus/
[21]
Brown, M.H., M. Weinberg, N. Chong, R. Levine and E. Holowaty, 1999. A cohort study of breast cancer risk in breast reduction patients. Plast. Reconstr. Surg., 103: 1674-1681.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186